Czech Innovation Against Alzheimer's: H2 Global Group Enters Key Growth Phase

"Hydrogen is the smallest molecule in the universe, yet it can protect our most valuable assets – memory and independence," explains Prof. Ohta. "Hydrogen is the smallest molecule in the universe, yet it can protect our most valuable assets – memory and independence,"explains Prof. Ohta. Group founder David Maršálek, who has been developing hydrogen technologies since 2011, adds:"Our mission is to launch the world's first hydrogen-based medical device for Alzheimer's prevention and...

London, 29/09/2025 (informazione.news - comunicati stampa - salute e benessere)

explains Prof. Ohta.

Group founder David Maršálek, who has been developing hydrogen technologies since 2011, adds:

Between 2021 and 2025, H2 Global Group raised over funding, built a network of end-customers and 50+ B2B partners, and exceeded revenues of circa Current transactions value the group at circa .

Now entering the group plans to to fund global expansion into Europe , the U.S., the Middle East , and Africa , complete clinical trials, and secure EU and FDA registrations. Revenue projections forecast growth to nearly .

The portfolio extends beyond the medical device. H2 Medical Technologies supplies hydrogen generators and therapeutic systems to spas, sports clubs, physiotherapy practices or dental clinics. Its solutions are also approved for veterinary use. In parallel, develops consumer products such as H2 Premium Water®, H2 Brain®, H2 Forte®, and H2 Dent Care®, which are commercially successful and distributed via e-commerce and a B2B network.

Photo: https://mma.prnewswire.com/media/2784475/H2Global_David_LSI.jpg

View original content:https://www.prnewswire.co.uk/news-releases/czech-innovation-against-alzheimers-h2-global-group-enters-key-growth-phase-302569725.html